HASHICORP INC-CL A (HCP) Stock Fundamental Analysis

NASDAQ:HCP • US4181001037

34.78 USD
-0.03 (-0.09%)
At close: Feb 26, 2025
34.98 USD
+0.2 (+0.58%)
After Hours: 2/26/2025, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

HCP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 274 industry peers in the Software industry. No worries on liquidiy or solvency for HCP as it has an excellent financial health rating, but there are worries on the profitability. HCP is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • HCP had positive earnings in the past year.
  • In the past year HCP had a positive cash flow from operations.
  • In the past 5 years HCP always reported negative net income.
  • HCP had a negative operating cash flow in each of the past 5 years.
HCP Yearly Net Income VS EBIT VS OCF VS FCFHCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M -250M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.22%, HCP is in line with its industry, outperforming 43.11% of the companies in the same industry.
  • With a Return On Equity value of -9.72%, HCP perfoms like the industry average, outperforming 49.82% of the companies in the same industry.
Industry RankSector Rank
ROA -7.22%
ROE -9.72%
ROIC N/A
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
HCP Yearly ROA, ROE, ROICHCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • HCP has a Gross Margin of 82.09%. This is amongst the best in the industry. HCP outperforms 86.93% of its industry peers.
  • In the last couple of years the Gross Margin of HCP has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for HCP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
HCP Yearly Profit, Operating, Gross MarginsHCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • HCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, HCP has more shares outstanding
  • There is no outstanding debt for HCP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HCP Yearly Shares OutstandingHCP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
HCP Yearly Total Debt VS Total AssetsHCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • HCP has an Altman-Z score of 9.80. This indicates that HCP is financially healthy and has little risk of bankruptcy at the moment.
  • HCP has a Altman-Z score of 9.80. This is amongst the best in the industry. HCP outperforms 85.87% of its industry peers.
  • HCP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.8
ROIC/WACCN/A
WACC13.94%
HCP Yearly LT Debt VS Equity VS FCFHCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 3.79 indicates that HCP has no problem at all paying its short term obligations.
  • HCP has a better Current ratio (3.79) than 81.63% of its industry peers.
  • HCP has a Quick Ratio of 3.79. This indicates that HCP is financially healthy and has no problem in meeting its short term obligations.
  • HCP has a Quick ratio of 3.79. This is amongst the best in the industry. HCP outperforms 81.63% of its industry peers.
Industry RankSector Rank
Current Ratio 3.79
Quick Ratio 3.79
HCP Yearly Current Assets VS Current LiabilitesHCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • HCP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 247.62%, which is quite impressive.
  • The Revenue has grown by 16.30% in the past year. This is quite good.
  • HCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.00% yearly.
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%

3.2 Future

  • HCP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 118.92% yearly.
  • The Revenue is expected to grow by 15.37% on average over the next years. This is quite good.
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HCP Yearly Revenue VS EstimatesHCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
HCP Yearly EPS VS EstimatesHCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • HCP is valuated quite expensively with a Price/Earnings ratio of 112.19.
  • Compared to the rest of the industry, the Price/Earnings ratio of HCP is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, HCP is valued quite expensively.
  • A Price/Forward Earnings ratio of 71.87 indicates a quite expensive valuation of HCP.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of HCP is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.75, HCP is valued quite expensively.
Industry RankSector Rank
PE 112.19
Fwd PE 71.87
HCP Price Earnings VS Forward Price EarningsHCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as HCP.
Industry RankSector Rank
P/FCF 124.32
EV/EBITDA N/A
HCP Per share dataHCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • HCP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • HCP's earnings are expected to grow with 118.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y171.61%
EPS Next 3Y118.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

HASHICORP INC-CL A

NASDAQ:HCP (2/26/2025, 8:00:01 PM)

After market: 34.98 +0.2 (+0.58%)

34.78

-0.03 (-0.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-06
Earnings (Next)05-28
Inst Owners79.69%
Inst Owner Change-100%
Ins Owners3.97%
Ins Owner Change0%
Market Cap7.11B
Revenue(TTM)654.89M
Net Income(TTM)-122.22M
Analysts52
Price Target35.32 (1.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1179.36%
Min EPS beat(2)163.27%
Max EPS beat(2)2195.45%
EPS beat(4)4
Avg EPS beat(4)814.28%
Min EPS beat(4)163.27%
Max EPS beat(4)2195.45%
EPS beat(8)8
Avg EPS beat(8)447.11%
EPS beat(12)12
Avg EPS beat(12)310.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.35%
Min Revenue beat(2)3.98%
Max Revenue beat(2)4.72%
Revenue beat(4)4
Avg Revenue beat(4)3.95%
Min Revenue beat(4)3.32%
Max Revenue beat(4)4.72%
Revenue beat(8)8
Avg Revenue beat(8)3.78%
Revenue beat(12)12
Avg Revenue beat(12)5.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.2%
EPS NQ rev (1m)-2.58%
EPS NQ rev (3m)22.03%
EPS NY rev (1m)0%
EPS NY rev (3m)42.14%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 112.19
Fwd PE 71.87
P/S 10.86
P/FCF 124.32
P/OCF 104.53
P/B 5.65
P/tB 5.75
EV/EBITDA N/A
EPS(TTM)0.31
EY0.89%
EPS(NY)0.48
Fwd EY1.39%
FCF(TTM)0.28
FCFY0.8%
OCF(TTM)0.33
OCFY0.96%
SpS3.2
BVpS6.15
TBVpS6.05
PEG (NY)0.22
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.22%
ROE -9.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.09%
FCFM 8.73%
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 84.44%
Cap/Sales 1.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.79
Quick Ratio 3.79
Altman-Z 9.8
F-Score6
WACC13.94%
ROIC/WACCN/A
Cap/Depr(3y)195.54%
Cap/Depr(5y)361.24%
Cap/Sales(3y)2%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
EBIT growth 1Y37.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.63%
EBIT Next 3Y44.51%
EBIT Next 5YN/A
FCF growth 1Y156.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y173.12%
OCF growth 3YN/A
OCF growth 5YN/A

HASHICORP INC-CL A / HCP FAQ

What is the ChartMill fundamental rating of HASHICORP INC-CL A (HCP) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HCP.


What is the valuation status for HCP stock?

ChartMill assigns a valuation rating of 3 / 10 to HASHICORP INC-CL A (HCP). This can be considered as Overvalued.


What is the profitability of HCP stock?

HASHICORP INC-CL A (HCP) has a profitability rating of 2 / 10.


How financially healthy is HASHICORP INC-CL A?

The financial health rating of HASHICORP INC-CL A (HCP) is 8 / 10.